Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Iterum Therapeutics plc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −1 vs. Q3 2022
- Shares held
- 290.0K
- −27.8K (−8.7%) vs. Q3 2022
- Total value
- $243.7K
- −$331.5K (−57.6%) vs. Q3 2022
- New holders
- 3
- 4 more added
- Sold out
- 4
- 5 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $542 |
| Q1 2026 | 18 | $41.3K |
| Q4 2025 | 20 | $557.9K |
| Q3 2025 | 24 | $904.1K |
| Q2 2025 | 24 | $2.38M |
| Q1 2025 | 20 | $1.38M |
| Q4 2024 | 24 | $2.18M |
| Q3 2024 | 18 | $2.22M |
| Q2 2024 | 15 | $494.7K |
| Q1 2024 | 18 | $1.43M |
| Q4 2023 | 16 | $761.6K |
| Q3 2023 | 15 | $184.0K |
| Q2 2023 | 17 | $393.4K |
| Q1 2023 | 17 | $187.3K |
| Q4 2022 | 23 | $243.7K |
| Q3 2022 | 25 | $575.4K |
| Q2 2022 | 39 | $1.18M |
| Q1 2022 | 41 | $1.80M |
| Q4 2021 | 45 | $2.57M |
| Q3 2021 | 42 | $3.45M |
| Q2 2021 | 45 | $26.0M |
| Q1 2021 | 50 | $11.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Iterum Therapeutics plc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ancora Advisors, LLC | 38 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 12 | $0 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 100 | $0 | 0.00% | +100 | New |
| National Bank of Canada | 2 | $2 | 0.00% | 00.0% | Unchanged |
| HM Payson & Co | 3 | $3 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 13 | $11 | 0.00% | 00.0% | Unchanged |
| Cypress Capital Management LLC (WY) | 66 | $55 | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 78 | $66 | 0.00% | +78 | New |
| Wells Fargo & Company | 85 | $71 | 0.00% | −220−72.1% | Reduced |
| Kelly Financial Services LLC | 120 | $101 | 0.00% | 00.0% | Unchanged |
| Creative Financial Designs Inc | 200 | $168 | 0.00% | −1,000−83.3% | Reduced |
| The PNC Financial Services Group, Inc. | 445 | $374 | 0.00% | +12+2.8% | Added |
| Tower Research Capital LLC (TRC) | 4,401 | $4.00K | 0.00% | +3,079+232.9% | Added |
| Focused Wealth Management, Inc | 6,999 | $5.88K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8,490 | $7.13K | 0.00% | −1,157−12.0% | Reduced |
| UBS Group AG | 15,264 | $12.8K | 0.00% | +6,943+83.4% | Added |
| Franklin Resources Inc | 17,427 | $14.6K | 0.00% | 00.0% | Unchanged |
| Krilogy Financial LLC | 20,000 | $16.8K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 23,223 | $20.0K | 0.00% | +23,223 | New |
| Renaissance Technologies LLC | 37,084 | $31.0K | 0.00% | +2,400+6.9% | Added |
| Dimensional Fund Advisors LP | 58,497 | $49.0K | 0.00% | −3,804−6.1% | Reduced |
| New Leaf Venture Partners, L.L.C. | 97,084 | $81.6K | 0.06% | 00.0% | Unchanged |
| IFP Advisors, Inc | 399 | – | – | −5,601−93.4% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −30,479−100.0% | Sold out |
| Grimes & Company, Inc. | 0 | $0 | 0.00% | −14,641−100.0% | Sold out |
| Edmond de Rothschild Holding S.A. | 0 | $0 | 0.00% | −6,666−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |